American International Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,431
Closed -$183K 1389
2024
Q1
$183K Buy
15,431
+42
+0.3% +$498 ﹤0.01% 2198
2023
Q4
$189K Buy
15,389
+3,099
+25% +$38K ﹤0.01% 2203
2023
Q3
$118K Buy
12,290
+437
+4% +$4.21K ﹤0.01% 2414
2023
Q2
$107K Buy
11,853
+39
+0.3% +$351 ﹤0.01% 2534
2023
Q1
$92.9K Buy
11,814
+235
+2% +$1.85K ﹤0.01% 2491
2022
Q4
$78.3K Sell
11,579
-42
-0.4% -$284 ﹤0.01% 2611
2022
Q3
$169K Buy
11,621
+165
+1% +$2.4K ﹤0.01% 2255
2022
Q2
$113K Buy
11,456
+337
+3% +$3.32K ﹤0.01% 2528
2022
Q1
$164K Sell
11,119
-782
-7% -$11.5K ﹤0.01% 2361
2021
Q4
$157K Buy
11,901
+1,021
+9% +$13.5K ﹤0.01% 2502
2021
Q3
$190K Sell
10,880
-259
-2% -$4.52K ﹤0.01% 2459
2021
Q2
$267 Buy
11,139
+34
+0.3% +$1 ﹤0.01% 2325
2021
Q1
$285 Buy
11,105
+2,619
+31% +$67 ﹤0.01% 2167
2020
Q4
$161 Buy
8,486
+332
+4% +$6 ﹤0.01% 2392
2020
Q3
$103K Sell
8,154
-186
-2% -$2.35K ﹤0.01% 2523
2020
Q2
$101K Buy
8,340
+868
+12% +$10.5K ﹤0.01% 2533
2020
Q1
$57K Sell
7,472
-431
-5% -$3.29K ﹤0.01% 2615
2019
Q4
$141K Buy
7,903
+532
+7% +$9.49K ﹤0.01% 2428
2019
Q3
$86K Sell
7,371
-50
-0.7% -$583 ﹤0.01% 2696
2019
Q2
$164K Buy
+7,421
New +$164K ﹤0.01% 2362
2016
Q2
Sell
-513
Closed -$5K 3830
2016
Q1
$5K Hold
513
﹤0.01% 4727
2015
Q4
$26K Sell
513
-1
-0.2% -$51 ﹤0.01% 4183
2015
Q3
$26K Hold
514
﹤0.01% 4184
2015
Q2
$51.4K Buy
+514
New +$51.4K ﹤0.01% 4037